BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12900588)

  • 1. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies.
    Smith DH; Cramer MJ; Neutel JM; Hettiarachchi R; Koval S
    Blood Press Monit; 2003 Jun; 8(3):111-7. PubMed ID: 12900588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
    Mallion J; Siche J; Lacourcière Y
    J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.
    Zhu JR; Bai J; Cai NS; Tang B; Fan WH; Guo JZ; Ke YN; Guo JX; Sheng LH; Lu ZY; Cheng NN
    Int J Clin Pract Suppl; 2004 Dec; (145):46-9. PubMed ID: 15617459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients.
    Lee YT; Lee CM; Lin CS; Sheu SH; Kuo WK; Tsai CW; Huang LC; Huang HC; Wang JS; Tseng WK
    Int J Clin Pract Suppl; 2004 Dec; (145):40-5. PubMed ID: 15617458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patients.
    Ding PY; Chu KM; Chiang HT; Shu KH
    Int J Clin Pract Suppl; 2004 Dec; (145):16-22. PubMed ID: 15617454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy.
    Gil-Extremera B; Ma PT; Yulde J; Kalnins U; Harkin N; Williams L
    Int J Clin Pract; 2003 Dec; 57(10):861-6. PubMed ID: 14712886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained antihypertensive activity of telmisartan compared with valsartan.
    Lacourcière Y; Krzesinski JM; White WB; Davidai G; Schumacher H
    Blood Press Monit; 2004 Aug; 9(4):203-10. PubMed ID: 15311147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
    Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
    Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs.
    Neutel JM
    Blood Press Monit; 2000; 5 Suppl 1():S35-40. PubMed ID: 10904241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension.
    Amerena J; Pappas S; Ouellet JP; Williams L; O'Shaughnessy D
    J Int Med Res; 2002; 30(6):543-52. PubMed ID: 12526280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).
    Williams B; Gosse P; Lowe L; Harper R;
    J Hypertens; 2006 Jan; 24(1):193-200. PubMed ID: 16331118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.
    Rysavá R; Tesar V; Merta M;
    Blood Press Monit; 2005 Aug; 10(4):207-13. PubMed ID: 16077267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators.
    Asmar R; Lacourcière Y
    J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.